SCI Pharmtech, Inc. (TPE:4119)
Taiwan · Delayed Price · Currency is TWD 53.80
-0.80 (-1.47%)
Sep 8, 2026, 1:30 PM CST
SCI Pharmtech Market Cap
SCI Pharmtech has a market cap or net worth of 6.43 billion as of September 4, 2026. Its market cap has decreased by -11.07% in one year.
Market Cap
6.43B
Enterprise Value
7.41B
Revenue
1.26B
Ranking
n/a
PE Ratio
107.51
Stock Price
53.80
ChartMarket Cap Chart
Since January 5, 2004, SCI Pharmtech's market cap has increased from 1.06B to 6.43B, an increase of 503.85%. That is a compound annual growth rate of 8.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 6.43B | 10.47% |
| Dec 31, 2025 | 5.82B | -46.25% |
| Dec 31, 2024 | 10.83B | -6.40% |
| Dec 29, 2023 | 11.57B | 24.39% |
| Dec 30, 2022 | 9.30B | 16.07% |
| Dec 30, 2021 | 8.01B | 20.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grape King Bio | 13.48B |
| Foresee Pharmaceuticals | 13.08B |
| Standard Chemical & Pharmaceutical | 10.04B |
| Alar Pharmaceuticals | 6.28B |
| Orient Pharma | 6.09B |
| Formosa Laboratories | 5.58B |
| Panion & Bf Biotech | 4.84B |
| LIWANLI Innovation | 4.66B |